Profilo
Guido Maertens is the founder of Enzyre BV.
He previously worked as a Controller at Pharming Group NV, Chief Financial Officer at ACS Biomarker BV, and Finance Consultant at First Dutch Capital BV.
He graduated from the University of Tilburg.
Posizioni attive di Guido Maertens
| Società | Posizione | Inizio |
|---|---|---|
Enzyre BV
 Enzyre BV Packaged SoftwareTechnology Services Enzyre BV develops biochip platform that enzymatic reactions can be measured. The company is headquartered in Nijmegen, the Netherlands. | Fondatore | - |
Precedenti posizioni note di Guido Maertens
| Società | Posizione | Fine |
|---|---|---|
First Dutch Capital BV
 First Dutch Capital BV Investment ManagersFinance First Dutch Capital BV is a company based in Amsterdam, Netherlands that was founded by Walter van Damme. The private company is focused on empowering human progress and is a family of companies that operate in the energy, health, and technology sectors. | Corporate Officer/Principal | - |
| PHARMING GROUP N.V. | Comptroller/Controller/Auditor | - |
ACS Biomarker BV
 ACS Biomarker BV Medical SpecialtiesHealth Technology ACS Biomarker BV develops and commercializes cardiovascular biomarkers. The firm offers miRNA profiling services. It engages in the discovery, validation, and commercialization of biomarkers that improve diagnosis, prognosis and management of cardiac diseases. The company was founded in 2007 by Mat J. A. P. Daemen, Yigal M. Pinto and Tilman Hackeng and is headquartered in Maastricht, the Netherlands. | Direttore Finanziario/CFO | - |
Formazione di Guido Maertens
| University of Tilburg | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| PHARMING GROUP N.V. | Health Technology |
| Aziende private | 3 |
|---|---|
ACS Biomarker BV
ACS Biomarker BV Medical SpecialtiesHealth Technology ACS Biomarker BV develops and commercializes cardiovascular biomarkers. The firm offers miRNA profiling services. It engages in the discovery, validation, and commercialization of biomarkers that improve diagnosis, prognosis and management of cardiac diseases. The company was founded in 2007 by Mat J. A. P. Daemen, Yigal M. Pinto and Tilman Hackeng and is headquartered in Maastricht, the Netherlands. | Health Technology |
First Dutch Capital BV
First Dutch Capital BV Investment ManagersFinance First Dutch Capital BV is a company based in Amsterdam, Netherlands that was founded by Walter van Damme. The private company is focused on empowering human progress and is a family of companies that operate in the energy, health, and technology sectors. | Finance |
Enzyre BV
Enzyre BV Packaged SoftwareTechnology Services Enzyre BV develops biochip platform that enzymatic reactions can be measured. The company is headquartered in Nijmegen, the Netherlands. | Technology Services |
- Borsa valori
- Insiders
- Guido Maertens
